Ocuphire Pharma
zeta phase trial of oral in subjects with diabetic ode | Ocuphire Pharma
Company
Deck Type
Deck date
August 2023
Slide
20 of 42
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Presentation
November 2023
zeta phase trial of oral in subjects with diabetic ode | Ocuphire Pharma
Investor Presentation
May 2023
zeta phase design in | Ocuphire Pharma
Related slides by other companies
Arbutus Biopharma
Investor Presentation
November 2023
phase a clinical trial a placebo weeks will be presented at | Arbutus Biopharma
Oculis
Investor Conference
June 2023
first eye drop for | Oculis
ATAI
Investor Presentation
March 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
MindMed
Investor Presentation
December 2024
phase gad part a schematics two pivotal studies with complementary designs designs as panorama | MindMed
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
May 2023
Results
January 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights